These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 26314714

  • 21. Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.
    Jacobs-van der Bruggen MA, Engelfriet PM, Hoogenveen RT, van Baal PH, Struijs JN, Verschuren WM, Smit HA, Baan CA.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):521-5. PubMed ID: 18830084
    [Abstract] [Full Text] [Related]

  • 22. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [Abstract] [Full Text] [Related]

  • 23. The concept of the polypill in the prevention of cardiovascular disease.
    Wiley B, Fuster V.
    Ann Glob Health; 2014 Jul; 80(1):24-34. PubMed ID: 24751562
    [Abstract] [Full Text] [Related]

  • 24. Population health impact of statin treatment in Canada.
    Hennessy DA, Tanuseputro P, Tuna M, Bennett C, Perez R, Shields M, Ko DT, Tu J, Manuel DG.
    Health Rep; 2016 Jan 20; 27(1):20-8. PubMed ID: 26788719
    [Abstract] [Full Text] [Related]

  • 25. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
    Karlsson SA, Hero C, Svensson AM, Franzén S, Miftaraj M, Gudbjörnsdottir S, Eeg-Olofsson K, Eliasson B, Andersson Sundell K.
    BMJ Open; 2018 Mar 30; 8(3):e020309. PubMed ID: 29602853
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY, Ko SK, Liew D.
    Clin Ther; 2009 Dec 30; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treatment and Response to Statins: Gender-related Differences.
    Raparelli V, Pannitteri G, Todisco T, Toriello F, Napoleone L, Manfredini R, Basili S.
    Curr Med Chem; 2017 Dec 30; 24(24):2628-2638. PubMed ID: 28552051
    [Abstract] [Full Text] [Related]

  • 35. A Survey of GPs Awareness and Use of Risk Assessment Tools and Cardiovascular Disease Prevention Guidelines.
    Byrne D, O'Connor L, Jennings S, Bennett K, Murphy AW.
    Ir Med J; 2015 Dec 30; 108(7):204-7. PubMed ID: 26349349
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.
    Clin Ther; 2008 Nov 30; 30(11):2167-79. PubMed ID: 19108805
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.